cardiotomskСибирский журнал клинической и экспериментальной медициныSiberian Journal of Clinical and Experimental Medicine2713-29272713-265XTSU publishing10.29001/2073-8552-2021-36-1-38-48cardiotomsk-1130Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEWS AND LECTURESПоражение сердца и роль ультразвукового исследования в условиях пандемии COVID-19Heart damage and the role of ultrasonic research in the COVID-19 pandemichttps://orcid.org/0000-0002-3081-9477ПавлюковаЕ. Н.PavlyukovaE. N.

 д-р мед. наук, профессор, заведующий отделением атеросклероза и хронической ишемической болезни сердцаE-mail: pavluk@cardio-tomsk.ru;  

 634012, Российская Федерация, Томск, ул. Киевская, 111а 

  Dr. Sci. (Med.), Professor, Head of the Department of Atherosclerosis and Coronary Artery Disease

111a, Kievskaya str., Tomsk, 634012, Russian Federation 

pavlyukovaelena@yandex.ruhttps://orcid.org/0000-0002-2627-3272СкиданВ. И.SkidanV. I.

 канд. мед. наук, врач

680009, Российская Федерация, Хабаровск, ул. Краснодарская, 2в 

  Cand. Sci. (Med.), Medical Doctor

2v, Krasnodarskaya str., Khabarovsk, 680009, Russian Federation 

Skivi5@yandex.ruhttps://orcid.org/0000-0003-0784-2246РоссейкинЕ. В.RosseikinE. V.

 д-р мед. наук, врач-сердечно-сосудистый хирург, главный врач 

680009, Российская Федерация, Хабаровск, ул. Краснодарская, 2в 

 Dr. Sci. (Med.), Cardiovascular Surgeon, Chief Physician

 2v, Krasnodarskaya str., Khabarovsk, 680009, Russian Federation 

rosseykin@mail.ruhttps://orcid.org/0000-0001-6322-1087НарциссоваГ. П.NartsissovaG. P.

  д-р мед. наук, врач функциональной диагностики консультативно-диагностического центра № 1, ведущийнаучный сотрудник группы функциональной и ультразвуковой диагностики центра новых технологий 

630055, Российская Федерация, Новосибирск, ул. Речкуновская, 15 

  Dr. Sci. (Med.), Physician of Functional Diagnostics, Consultative and Diagnostic Center No. 1, Leading Research Scientist, Group of Functional and Ultrasound Diagnostics, Center for New Technologies

15, Rechkunovskaya str., Novosibirsk, 630055, Russian Federation 

galinar@yadex.ruhttps://orcid.org/0000-0002-7011-4316КарповР. С.KarpovR. S.

 академик РАН, научный руководитель E-mail: tvk@cardio-tomsk.ru

 634012, Российская Федерация, Томск, ул. Киевская, 111а 

  Dr. Sci. (Med.), Full Member of the Russian Academy of Sciences, Chief Research Scientist

111a, Kievskaya str., Tomsk, 634012, Russian Federation 

karpov@cardio-tomsk.ruНаучно-исследовательский институт кардиологии, Томский национальный исследовательский медицинский центр Российской академии наукРоссияCardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of SciencesRussian FederationФедеральный Центр сердечно-сосудистой хирургии Министерства здравоохранения Российской ФедерацииРоссияFederal Center for Cardiovascular SurgeryRussian FederationНациональный медицинский исследовательский центр имени академика Е.Н. Мешалкина Министерства здравоохранения Российской ФедерацииРоссияNational Medical Research Center named after Academician E.N. MeshalkinRussian Federation2021010420213613848Copyright © Павлюкова Е.Н., Скидан В.И., Россейкин Е.В., Нарциссова Г.П., Карпов Р.С., 20212021Павлюкова Е.Н., Скидан В.И., Россейкин Е.В., Нарциссова Г.П., Карпов Р.С.Pavlyukova E.N., Skidan V.I., Rosseikin E.V., Nartsissova G.P., Karpov R.S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.sibjcem.ru/jour/article/view/1130

 Обзор литературы касается поражения сердца при COVID-19. Представлен протокол ультразвукового исследования «point-of-care ultrasound (POCUS)» для пациентов с COVID-19. Показана целесообразность оценки механики левого (ЛЖ) и правого желудочков (ПЖ) у больных COVID-19. 

 This literature review focuses on the damage to the heart in the presence of coronavirus disease (COVID-19). A point-of-care ultrasound (POCUS) protocol for patients with COVID-19 is presented. The advisability of assessing the mechanics of the left and right ventricles in COVID-19 patients is demonstrated. 

COVID-19поражение сердцамиокардитэхокардиографияправый желудочекглобальная деформация правого желудочкаглобальная деформация левого желудочкапротокол ультразвукового исследования «point-of-care ultrasound (POCUS)»COVID-19heart damagemyocarditisechocardiographyright ventricular global longitudinal strainleft ventricular global longitudinal strainpoint-of-care ultrasoundPOCUSReferencesКоронавирус. Статистика коронавируса. URL: https://coronavirus-stata.ru/statistika-koronavirusa-v-mire-na-20-oktyabrya-2020-goda/.Сoronavirus. Сoronavirus statistics (In Russ.). URL: https://coronavirus-stata.ru/statistika-koronavirusa-v-mire-na-20-oktyabrya-2020-goda/.Yan R., Zhang Y., Li Y., Xia L., Guo Y., Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 2020;367(6485):1444–1448. DOI: 10.1126/science.abb2762.Yan R., Zhang Y., Li Y., Xia L., Guo Y., Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 2020;367(6485):1444–1448. DOI: 10.1126/science.abb2762.Временные методические рекомендации. Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19)»; версия 8.1 от 01.10.2020. М.: Министерство здравоохранения Российской Федерации; 2020:226.Temporary guidelines. Prevention, diagnosis and treatment of new coronavirus infection (COVID-19); version 8.1 of 01.10.2020. Moscow: Ministry of Health of Russian Federation; 2020:226 (In Russ.).Шляхто Е.В., Конради А.О., Виллевальде С.В., Звартау Н., Яковлев А.Н., Соловьева А.Е. и др. Руководство по диагностике и лечению болезней системы кровообращения (БСК) в контексте пандемии COVID-19 (краткая версия). М.; 2020:36.Shlyakhto E.V., Konradi A.O., Villevalde S.V., Zvartau N., Yakovlev A.N., Solov’eva A.E. et al. Guidelines for the diagnosis and treatment of diseases of the circulatory system (BSC) in the context of the COVID-19 pandemic (short version). Moscow; 2020:36 (In Russ.).Zheng Y.Y., Ma Y.T., Zhang J.Y., Xie X. COVID-19 and the cardiovascular system. Nat. Rev. Cardiol. 2020;17(5):259–260. DOI: 10.1038/s41569-020-0360-5.Zheng Y.Y., Ma Y.T., Zhang J.Y., Xie X. COVID-19 and the cardiovascular system. Nat. Rev. Cardiol. 2020;17(5):259–260. DOI: 10.1038/s41569-020-0360-5.Clerkin K.J., Fried J.A., Raikhelkar J., Sayer G., Griffin J.M., Masoumi A. et al. COVID-19 and cardiovascular disease. Circulation. 2020;141(20):1648–1655. DOI: 10.1161/CIRCULATIONAHA.120.046941.Clerkin K.J., Fried J.A., Raikhelkar J., Sayer G., Griffin J.M., Masoumi A. et al. COVID-19 and cardiovascular disease. Circulation. 2020;141(20):1648–1655. DOI: 10.1161/CIRCULATIONAHA.120.046941.Meng X., Deng Y., Dai Z., Meng Z. COVID-19 and anosmia: A review based on up-to-date knowledge. Am. J. Otolaryngol. 2020;41(5):102581. DOI: 10.1016/j.amjoto.2020.102581.Meng X., Deng Y., Dai Z., Meng Z. COVID-19 and anosmia: A review based on up-to-date knowledge. Am. J. Otolaryngol. 2020;41(5):102581. DOI: 10.1016/j.amjoto.2020.102581.Siddiqi H.K., Mehra M.R. COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal. J. Heart Lung Transplant. 2020;39(5):405–407. DOI: 10.1016/j.healun.2020.03.012.Siddiqi H.K., Mehra M.R. COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal. J. Heart Lung Transplant. 2020;39(5):405–407. DOI: 10.1016/j.healun.2020.03.012.Grasselli G., Pesenti A., Cecconi M. Critical сare гtilization for the COVID-19 оutbreak in Lombardy, Italy: Early еxperience and forecast during an emergency response. JAMA. 2020;323(16):1545–1546. DOI: 10.1001/jama.2020.4031.Grasselli G., Pesenti A., Cecconi M. Critical сare гtilization for the COVID-19 оutbreak in Lombardy, Italy: Early еxperience and forecast during an emergency response. JAMA. 2020;323(16):1545–1546. DOI: 10.1001/jama.2020.4031.Bonow R.O., Fonarow G.C., O’Gara P.T., Yancy C.W. Association of сoronavirus disease 2019 (COVID-19) with myocardial injury and mortality. JAMA Cardiol. 2020;5(7):751–753. DOI: 10.1001/jamacardio.2020.1105.Bonow R.O., Fonarow G.C., O’Gara P.T., Yancy C.W. Association of сoronavirus disease 2019 (COVID-19) with myocardial injury and mortality. JAMA Cardiol. 2020;5(7):751–753. DOI: 10.1001/jamacardio.2020.1105.Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X. et al.; China Medical Treatment Expert Group for Covid-19. Clinical сharacteristics of сoronavirus disease 2019 in China. N. Engl. J. Med. 2020;382(18):1708–1720. DOI: 10.1056/NEJMoa2002032.Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X. et al.; China Medical Treatment Expert Group for Covid-19. Clinical сharacteristics of сoronavirus disease 2019 in China. N. Engl. J. Med. 2020;382(18):1708–1720. DOI: 10.1056/NEJMoa2002032.Xu Z., Shi L., Wang Y., Zhang J., Huang L., Zhang C. et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir. Med. 2020;8(4):420–422. DOI: 10.1016/S2213-2600(20)30076-X.Xu Z., Shi L., Wang Y., Zhang J., Huang L., Zhang C. et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir. Med. 2020;8(4):420–422. DOI: 10.1016/S2213-2600(20)30076-X.Alhogbani T. Acute myocarditis associated with novel Middle east respiratory syndrome coronavirus. Ann. Saudi Med. 2016;36(1):78– 80. DOI: 10.5144/0256-4947.2016.78.Alhogbani T. Acute myocarditis associated with novel Middle east respiratory syndrome coronavirus. Ann. Saudi Med. 2016;36(1):78– 80. DOI: 10.5144/0256-4947.2016.78.Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. DOI: 10.1016/S0140-6736(20)30183-5.Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. DOI: 10.1016/S0140-6736(20)30183-5.Shi S., Qin M., Shen B., Cai Y., Liu T., Yang F. et al. Association of сardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5(7):802–810. DOI: 10.1001/jamacardio.2020.0950.Shi S., Qin M., Shen B., Cai Y., Liu T., Yang F. et al. Association of сardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5(7):802–810. DOI: 10.1001/jamacardio.2020.0950.Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069. DOI: 10.1001/jama.2020.1585.Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069. DOI: 10.1001/jama.2020.1585.Guo T., Fan Y., Chen M., Wu X., Zhang L., He T. et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):811–818. DOI: 10.1001/jamacardio.2020.1017.Guo T., Fan Y., Chen M., Wu X., Zhang L., He T. et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):811–818. DOI: 10.1001/jamacardio.2020.1017.Long B., Brady W.J., Koyfman A., Gottlieb M. Cardiovascular complications in COVID-19. Am. J. Emerg. Med. 2020;38(7):1504– 1507. DOI: 10.1016/j.ajem.2020.04.048.Long B., Brady W.J., Koyfman A., Gottlieb M. Cardiovascular complications in COVID-19. Am. J. Emerg. Med. 2020;38(7):1504– 1507. DOI: 10.1016/j.ajem.2020.04.048.Ruan Q., Yang K., Wang W., Jiang L., Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(5):846–848. DOI: 10.1007/s00134-020-05991-x.Ruan Q., Yang K., Wang W., Jiang L., Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(5):846–848. DOI: 10.1007/s00134-020-05991-x.Akhmerov A., Marbán E. COVID-19 and the heart. Circ. Res. 2020;126(10):1443–1455. DOI: 10.1161/CIRCRESAHA.120.31.Akhmerov A., Marbán E. COVID-19 and the heart. Circ. Res. 2020;126(10):1443–1455. DOI: 10.1161/CIRCRESAHA.120.31.Yao X.H., Li T.Y., He Z.C., Ping Y.F., Liu H.W., Yu S.C. et al. A pathological report of three COVID-19 cases by minimally invasive autopsies. Zhonghua Bing Li Xue Za Zhi. 2020;49(5):411–417. DOI: 10.3760/cma.j.cn112151-20200312-00193.Yao X.H., Li T.Y., He Z.C., Ping Y.F., Liu H.W., Yu S.C. et al. A pathological report of three COVID-19 cases by minimally invasive autopsies. Zhonghua Bing Li Xue Za Zhi. 2020;49(5):411–417. DOI: 10.3760/cma.j.cn112151-20200312-00193.Aretz H.T. Myocarditis: Тhe Dallas criteria. Hum. Pathol. 1987;18(6):619–624. DOI: 10.1016/s0046-8177(87)80363-5.Aretz H.T. Myocarditis: Тhe Dallas criteria. Hum. Pathol. 1987;18(6):619–624. DOI: 10.1016/s0046-8177(87)80363-5.Fung G., Luo H., Qiu Y., Yang D., McManus B. Myocarditis. Circ. Res. 2016;118(3):496–514. DOI: 10.1161/CIRCRESAHA.115.306573.Fung G., Luo H., Qiu Y., Yang D., McManus B. Myocarditis. Circ. Res. 2016;118(3):496–514. DOI: 10.1161/CIRCRESAHA.115.306573.Oudit G.Y., Kassiri Z., Jiang C., Liu P.P., Poutanen S.M., Penninger J.M. et al. SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur. J. Clin. Invest. 2009;39(7):618–625. DOI: 10.1111/j.1365-2362.2009.02153.x.Oudit G.Y., Kassiri Z., Jiang C., Liu P.P., Poutanen S.M., Penninger J.M. et al. SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur. J. Clin. Invest. 2009;39(7):618–625. DOI: 10.1111/j.1365-2362.2009.02153.x.Garvin M.R., Alvarez C., Miller J.I., Prates E.T., Walker A.M., Amos B.K. et al. A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm. Elife. 2020;9:e59177. DOI: 10.7554/eLife.59177.Garvin M.R., Alvarez C., Miller J.I., Prates E.T., Walker A.M., Amos B.K. et al. A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm. Elife. 2020;9:e59177. DOI: 10.7554/eLife.59177.Зайратьянц О.В., Самсонова О.В., Михайлева Л.М., Черняев А.Л., Мишнев О.Д., Крупнов Н.М. и др.; под общ ред. О.В. Зайратьянца. Патологическая анатомия COVID-19: атлас. М.; 2020:120.Zairatiants O.V., Samsonova O.V., Mikhailova L.M., Chernyaev A.L., Mishnev O.D., Krupnov N.M. et al.; edit. by O.V. Zayratyants. Pathological anatomy of COVID 19: Atlas. Moscow; 2020:120 (In Russ.).Klok F.A., Kruip M.J.H.A., van der Meer N.J.M., Arbous M.S., Gommers D., Kant K.M. et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis. Thromb. Res. 2020;191:148–150. DOI: 10.1016/j.thromres.2020.04.041.Klok F.A., Kruip M.J.H.A., van der Meer N.J.M., Arbous M.S., Gommers D., Kant K.M. et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis. Thromb. Res. 2020;191:148–150. DOI: 10.1016/j.thromres.2020.04.041.Desai H.D., Jadeja D.M., Sharma K. Takotsubo syndrome a rare entity in patients with COVID-19: An updated review of case-reports and case-series. Int. J. Cardiol. Heart Vasc. 2020;29:100604. DOI: 10.1016/j.ijcha.2020.100604.Desai H.D., Jadeja D.M., Sharma K. Takotsubo syndrome a rare entity in patients with COVID-19: An updated review of case-reports and case-series. Int. J. Cardiol. Heart Vasc. 2020;29:100604. DOI: 10.1016/j.ijcha.2020.100604.Faqihi F., Alharthy A., Alshaya R., Papanikolaou J., Kutsogiannis D.J., Brindley P.G. et al. Reverse takotsubo cardiomyopathy in fulminant COVID-19 associated with cytokine release syndrome and resolution following therapeutic plasma exchange: a case-report. BMC Cardiovasc. Disord. 2020;20(1):389. DOI: 10.1186/s12872-020-01665-0.Faqihi F., Alharthy A., Alshaya R., Papanikolaou J., Kutsogiannis D.J., Brindley P.G. et al. Reverse takotsubo cardiomyopathy in fulminant COVID-19 associated with cytokine release syndrome and resolution following therapeutic plasma exchange: a case-report. BMC Cardiovasc. Disord. 2020;20(1):389. DOI: 10.1186/s12872-020-01665-0.Dabbagh M.F., Aurora L., D’Souza P., Weinmann A.J., Bhargava P., Basir M.B. et al. Cardiac tamponade secondary to COVID-19. JACC Case Rep. 2020;2(9):1326–1330. DOI: 10.1016/j.jaccas.2020.04.009.Dabbagh M.F., Aurora L., D’Souza P., Weinmann A.J., Bhargava P., Basir M.B. et al. Cardiac tamponade secondary to COVID-19. JACC Case Rep. 2020;2(9):1326–1330. DOI: 10.1016/j.jaccas.2020.04.009.Sala S., Peretto G., Gramegna M., Palmisano A., Villatore A., Vignale D. et al. Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection. Eur. Heart J. 2020;41(19):1861–1862. DOI: 10.1093/eurheartj/ehaa286.Sala S., Peretto G., Gramegna M., Palmisano A., Villatore A., Vignale D. et al. Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection. Eur. Heart J. 2020;41(19):1861–1862. DOI: 10.1093/eurheartj/ehaa286.Li B., Yang J., Zhao F., Zhi L., Wang X., Liu L. et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin. Res. Cardiol. 2020;109(5):531–538. DOI: 10.1007/s00392-020-01626-9.Li B., Yang J., Zhao F., Zhi L., Wang X., Liu L. et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin. Res. Cardiol. 2020;109(5):531–538. DOI: 10.1007/s00392-020-01626-9.Capotosto L., Nguyen B.L., Ciardi M.R., Mastroianni C., Vitarelli A. Heart, COVID-19, and echocardiography. Echocardiography. 2020;37(9):1454–1464. DOI: 10.1111/echo.14834.Capotosto L., Nguyen B.L., Ciardi M.R., Mastroianni C., Vitarelli A. Heart, COVID-19, and echocardiography. Echocardiography. 2020;37(9):1454–1464. DOI: 10.1111/echo.14834.Babapoor-Farrokhran S., Gill D., Walker J., Rasekhi R.T., Bozorgnia B., Amanullah A. Myocardial injury and COVID-19: Possible mechanisms. Life Sci. 2020;253:117723. DOI: 10.1016/j.lfs.2020.117723.Babapoor-Farrokhran S., Gill D., Walker J., Rasekhi R.T., Bozorgnia B., Amanullah A. Myocardial injury and COVID-19: Possible mechanisms. Life Sci. 2020;253:117723. DOI: 10.1016/j.lfs.2020.117723.Lippi G., Lavie C.J., Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis. Prog. Cardiovasc. Dis. 2020;63(3):390–391. DOI: 10.1016/j.pcad.2020.03.001.Lippi G., Lavie C.J., Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis. Prog. Cardiovasc. Dis. 2020;63(3):390–391. DOI: 10.1016/j.pcad.2020.03.001.Fang L., Karakiulakis G., Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir. Med. 2020;8(4):e21. DOI: 10.1016/S2213-2600(20)30116-8.Fang L., Karakiulakis G., Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir. Med. 2020;8(4):e21. DOI: 10.1016/S2213-2600(20)30116-8.Kuster G.M., Pfister O., Burkard T., Zhou Q., Twerenbold R., Haaf P. et al. SARS-CoV2: Should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19? Eur. Heart J. 2020;41(19):1801–1803. DOI: 10.1093/eurheartj/ehaa235.Kuster G.M., Pfister O., Burkard T., Zhou Q., Twerenbold R., Haaf P. et al. SARS-CoV2: Should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19? Eur. Heart J. 2020;41(19):1801–1803. DOI: 10.1093/eurheartj/ehaa235.Ferrario C.M., Jessup J., Chappell M.C., Averill D.B., Brosnihan K.B., Tallant E.A. et al. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. 2005;111(20):2605–2610. DOI: 10.1161/CIRCULATIONAHA.104.510461.Ferrario C.M., Jessup J., Chappell M.C., Averill D.B., Brosnihan K.B., Tallant E.A. et al. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. 2005;111(20):2605–2610. DOI: 10.1161/CIRCULATIONAHA.104.510461.Sun M.L., Yang J.M., Sun Y.P., Su G.H. Inhibitors of RAS might be a good choice for the therapy of COVID-19 pneumonia. ZhonghuaSun M.L., Yang J.M., Sun Y.P., Su G.H. Inhibitors of RAS might be a good choice for the therapy of COVID-19 pneumonia. ZhonghuaJie He He Hu Xi Za Zhi. 2020;43(3):219–222. DOI: 10.3760/cma.j.is sn.1001-0939.2020.03.016.Jie He He Hu Xi Za Zhi. 2020;43(3):219–222. DOI: 10.3760/cma.j.is sn.1001-0939.2020.03.016.Danser A.H.J., Epstein M., Batlle D. Renin-angiotensin system blockers and the COVID-19 pandemic: At present there is no evidence to abandon renin-angiotensin system blockers. Hypertension. 2020;75(6):1382–1385. DOI: 10.1161/HYPERTENSIONAHA.120.15082.Danser A.H.J., Epstein M., Batlle D. Renin-angiotensin system blockers and the COVID-19 pandemic: At present there is no evidence to abandon renin-angiotensin system blockers. Hypertension. 2020;75(6):1382–1385. DOI: 10.1161/HYPERTENSIONAHA.120.15082.Vaduganathan M., Vardeny O., Michel T., McMurray J.J.V., Pfeffer M.A., Solomon S.D. Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19. N. Engl. J. Med. 2020;382(17):1653–1659. DOI: 10.1056/NEJMsr2005760.Vaduganathan M., Vardeny O., Michel T., McMurray J.J.V., Pfeffer M.A., Solomon S.D. Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19. N. Engl. J. Med. 2020;382(17):1653–1659. DOI: 10.1056/NEJMsr2005760.Inciardi R.M., Lupi L., Zaccone G., Italia L., Raffo M., Tomasoni D. et al. Cardiac involvement in a patient with coronavirus disease 2019Inciardi R.M., Lupi L., Zaccone G., Italia L., Raffo M., Tomasoni D. et al. Cardiac involvement in a patient with coronavirus disease 2019(COVID-19). JAMA Cardiol. 2020;5(7):819–824. DOI: 10.1001/jamacardio.2020.1096.(COVID-19). JAMA Cardiol. 2020;5(7):819–824. DOI: 10.1001/jamacardio.2020.1096.Deshotels M.R., Xia H., Sriramula S., Lazartigues E., Filipeanu C.M. Angiotensin II mediates an-giotensin converting enzyme type 2 internalization and degradation through an angiotensin II type I receptor-dependent mechanism. Hypertension. 2014;64(6):1368–1375. DOI: 10.1161/HYPERTENSIONAHA.114.03743.Deshotels M.R., Xia H., Sriramula S., Lazartigues E., Filipeanu C.M. Angiotensin II mediates an-giotensin converting enzyme type 2 internalization and degradation through an angiotensin II type I receptor-dependent mechanism. Hypertension. 2014;64(6):1368–1375. DOI: 10.1161/HYPERTENSIONAHA.114.03743.Shah P.B., Welt F.G.P., Mahmud E. Triage considerations for patients referred for structural heart disease intervention during the coronavirus disease 2019 (COVID-19) pandemic: An ACC /SCAI Consensus Statement. JACC Cardiovasc. Interv. 2020;13(12):1484–1488. DOI: 10.1016/j.jcin.2020.04.001.Shah P.B., Welt F.G.P., Mahmud E. Triage considerations for patients referred for structural heart disease intervention during the coronavirus disease 2019 (COVID-19) pandemic: An ACC /SCAI Consensus Statement. JACC Cardiovasc. Interv. 2020;13(12):1484–1488. DOI: 10.1016/j.jcin.2020.04.001.Tan W., Aboulhosn J. The cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease. Int. J. Cardiol. 2020;309:70–77. DOI: 10.1016/j.ijcard.2020.03.063.Tan W., Aboulhosn J. The cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease. Int. J. Cardiol. 2020;309:70–77. DOI: 10.1016/j.ijcard.2020.03.063.Liu K., Fang Y.Y., Deng Y., Liu W., Wang M.F., Ma J.P. et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei province. Chin. Med. J. (Engl.). 2020;133(9):1025–1031. DOI: 10.1097/CM9.0000000000000744.Liu K., Fang Y.Y., Deng Y., Liu W., Wang M.F., Ma J.P. et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei province. Chin. Med. J. (Engl.). 2020;133(9):1025–1031. DOI: 10.1097/CM9.0000000000000744.Chen C., Chen C., Yan J.T., Zhou N., Zhao J.P., Wang D.W. Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19. Zhonghua Xin Xue Guan Bing Za Zhi. 2020;48(7):567–571. DOI: 10.3760/cma.j.cn112148-20200225-00123.Chen C., Chen C., Yan J.T., Zhou N., Zhao J.P., Wang D.W. Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19. Zhonghua Xin Xue Guan Bing Za Zhi. 2020;48(7):567–571. DOI: 10.3760/cma.j.cn112148-20200225-00123.Yang X., Yu Y., Xu J., Shu H., Xia J., Liu H. et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study. Lancet Respir. Med. 2020;8(5):475–481. DOI: 10.1016/S2213-2600(20)30079-5.Yang X., Yu Y., Xu J., Shu H., Xia J., Liu H. et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study. Lancet Respir. Med. 2020;8(5):475–481. DOI: 10.1016/S2213-2600(20)30079-5.Alon D., Stein G.Y., Korenfeld R., Fuchs S. Predictors and outcomes of infection-related hospital admissions of heart failure patients. PLoS One. 2013;8(8):e72476. DOI: 10.1371/journal.pone.0072476.Alon D., Stein G.Y., Korenfeld R., Fuchs S. Predictors and outcomes of infection-related hospital admissions of heart failure patients. PLoS One. 2013;8(8):e72476. DOI: 10.1371/journal.pone.0072476.Arentz M., Yim E., Klaff L., Lokhandwala S., Riedo F.X., Chong M. et al. Characteristics and outcomes of 21 critically Ill patients with COVID-19 in Washington State. JAMA. 2020;323(16):1612–1614. DOI: 10.1001/jama.2020.4326.Arentz M., Yim E., Klaff L., Lokhandwala S., Riedo F.X., Chong M. et al. Characteristics and outcomes of 21 critically Ill patients with COVID-19 in Washington State. JAMA. 2020;323(16):1612–1614. DOI: 10.1001/jama.2020.4326.Szekely Y., Lichter Y., Taieb P., Banai A., Hochstadt A., Merdler I. et al. Spectrum of Cardiac Manifestations in COVID-19: A Systematic Echocardiographic Study. Circulation. 2020;142(4):342–353. DOI: 10.1161/CIRCULATIONAHA.120.047971.Szekely Y., Lichter Y., Taieb P., Banai A., Hochstadt A., Merdler I. et al. Spectrum of Cardiac Manifestations in COVID-19: A Systematic Echocardiographic Study. Circulation. 2020;142(4):342–353. DOI: 10.1161/CIRCULATIONAHA.120.047971.Mehra M.R., Ruschitzka F. COVID-19 Illness and heart failure: A missing link? JACC Heart Fail. 2020;48(6):512–514. DOI: 10.1016/j.jchf.2020.03.004.Mehra M.R., Ruschitzka F. COVID-19 Illness and heart failure: A missing link? JACC Heart Fail. 2020;48(6):512–514. DOI: 10.1016/j.jchf.2020.03.004.Gao L., Jiang D., Wen X.S., Cheng X.C., Sun M., He B. et al. Prognostic value of NT-proBNP in patients with severe COVID-19. Respir. Res. 2020;21(1):83. DOI: 10.1186/s12931-020-01352-w.Gao L., Jiang D., Wen X.S., Cheng X.C., Sun M., He B. et al. Prognostic value of NT-proBNP in patients with severe COVID-19. Respir. Res. 2020;21(1):83. DOI: 10.1186/s12931-020-01352-w.D’Andrea A., Scarafile R., Riegler L., Liccardo B., Crescibene F., Cocchia R. et al. Right ventricular function and pulmonary pressures as independent predictors of survival in patients with COVID-19 pneumonia. JACC Cardiovasc. Imaging. 2020;13(1):2467–2468. DOI: 10.1016/j.jcmg.2020.06.004.D’Andrea A., Scarafile R., Riegler L., Liccardo B., Crescibene F., Cocchia R. et al. Right ventricular function and pulmonary pressures as independent predictors of survival in patients with COVID-19 pneumonia. JACC Cardiovasc. Imaging. 2020;13(1):2467–2468. DOI: 10.1016/j.jcmg.2020.06.004.Barman H.A., Atici A., Tekin E.A., Baycan O.F., Alici G., Meric B.K. et al. Echocardiographic features of patients with COVID-19 infection: A cross-sectional study. Int. J. Cardiovasc. Imaging. 2020;8:1–10. DOI: 10.1007/s10554-020-02051-9.Barman H.A., Atici A., Tekin E.A., Baycan O.F., Alici G., Meric B.K. et al. Echocardiographic features of patients with COVID-19 infection: A cross-sectional study. Int. J. Cardiovasc. Imaging. 2020;8:1–10. DOI: 10.1007/s10554-020-02051-9.Baycan O.F., Barman H.A., Atici A., Tatlisu A., Bolen F., Ergen P. et al. Evaluation of biventricular function in patients with COVID-19 using speckle tracking echocardiography. Int. J. Cardiovasc. Imaging. 2020;15:1–10. DOI: 10.1007/s10554-020-01968-5.Baycan O.F., Barman H.A., Atici A., Tatlisu A., Bolen F., Ergen P. et al. Evaluation of biventricular function in patients with COVID-19 using speckle tracking echocardiography. Int. J. Cardiovasc. Imaging. 2020;15:1–10. DOI: 10.1007/s10554-020-01968-5.Stöbe S., Richter S., Seige M., Stehr S., Laufs U., Hagendorff A. Echocardiographic characteristics of patients with SARS-CoV-2 infection. Clin. Res. Cardiol. 2020;109(12):1549–1566. DOI: 10.1007/s00392-020-01727-5.Stöbe S., Richter S., Seige M., Stehr S., Laufs U., Hagendorff A. Echocardiographic characteristics of patients with SARS-CoV-2 infection. Clin. Res. Cardiol. 2020;109(12):1549–1566. DOI: 10.1007/s00392-020-01727-5.Croft L.B., Krishnamoorthy P., Ro R., Anastasius M., Zhao W., Buckley S. et al. Abnormal left ventricular global longitudinal strain by speckle tracking echocardiography in COVID-19 patients. Future Cardiol. 2020;9:10.2217/fca-2020-0121. DOI: 10.2217/fca-2020-0121.Croft L.B., Krishnamoorthy P., Ro R., Anastasius M., Zhao W., Buckley S. et al. Abnormal left ventricular global longitudinal strain by speckle tracking echocardiography in COVID-19 patients. Future Cardiol. 2020;9:10.2217/fca-2020-0121. DOI: 10.2217/fca-2020-0121.Mahmoud-Elsayed H.M., Moody W.E., Bradlow W.M., Khan-Kheil A.M., Senior J., Hudsmith L.E. et al. Echocardiographic findings in patients with COVID-19 pneumonia. Can. J. Cardiol. 2020;36(8):1203–1207. DOI: 10.1016/j.cjca.2020.05.030.Mahmoud-Elsayed H.M., Moody W.E., Bradlow W.M., Khan-Kheil A.M., Senior J., Hudsmith L.E. et al. Echocardiographic findings in patients with COVID-19 pneumonia. Can. J. Cardiol. 2020;36(8):1203–1207. DOI: 10.1016/j.cjca.2020.05.030.Fayssoil A., Mustafic H., Mansencal N. The right ventricle in COVID-19 patients. Am. J. Cardiol. 2020;130:166–167. DOI: 10.1016/j.amjcard.2020.06.007.Fayssoil A., Mustafic H., Mansencal N. The right ventricle in COVID-19 patients. Am. J. Cardiol. 2020;130:166–167. DOI: 10.1016/j.amjcard.2020.06.007.Li Y., Li H., Zhu S., Xie Y., Wang B., He L. et al. Prognostic value of right ventricular longitudinal strain in patients with COVID-19. JACC Cardiovasc. Imaging. 2020;13(11):2287–2299. DOI: 10.1016/j.jcmg.2020.04.014.Li Y., Li H., Zhu S., Xie Y., Wang B., He L. et al. Prognostic value of right ventricular longitudinal strain in patients with COVID-19. JACC Cardiovasc. Imaging. 2020;13(11):2287–2299. DOI: 10.1016/j.jcmg.2020.04.014.Xiong T.Y., Redwood S., Prendergast B., Chen M. Coronaviruses and the cardiovascular system: acute and long-term implications. Eur. Heart J. 2020;41(19):1798–1800. DOI: 10.1093/eurheartj/ehaa231.Xiong T.Y., Redwood S., Prendergast B., Chen M. Coronaviruses and the cardiovascular system: acute and long-term implications. Eur. Heart J. 2020;41(19):1798–1800. DOI: 10.1093/eurheartj/ehaa231.Johri A.M., Galen B., Kirkpatrick J.N., Lanspa M., Mulvagh S., Thamman R. ASE statement on point-of-care ultrasound during the 2019 novel coronavirus pandemic. J. Am. Soc. Echocardiogr. 2020;33(6):670–673. DOI: 10.1016/j.echo.2020.04.017.Johri A.M., Galen B., Kirkpatrick J.N., Lanspa M., Mulvagh S., Thamman R. ASE statement on point-of-care ultrasound during the 2019 novel coronavirus pandemic. J. Am. Soc. Echocardiogr. 2020;33(6):670–673. DOI: 10.1016/j.echo.2020.04.017.Cardiovascular point-of-care imaging for the medical student and novice user. American Society of Echocardiography. URL: https://aseuniversity.org/ase/lessons/47 (available from March 25, 2020).Cardiovascular point-of-care imaging for the medical student and novice user. American Society of Echocardiography. URL: https://aseuniversity.org/ase/lessons/47 (available from March 25, 2020).

The authors declare that there are no conflicts of interest present.